Skip to content

Clinical trials

Phase 3 Bipolar Disorder trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 3 Country / region: Canada Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20051
20061
20071
20082
20091
20102
20112
20121
20141
20152
20161
20171
20181
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated4
Recruiting3
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of British Columbia4
Sumitomo Pharma America, Inc.3
University Health Network, Toronto3
AstraZeneca2
Nova Scotia Health Authority2
Abraham Nunes1
Cynthia Calkin1
Douglas Mental Health University Institute1
Lakshmi N Yatham1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder25
Major Depressive Disorder5
Schizophrenia3
Depressive Disorder, Treatment-Resistant2
Psychotic Disorders2
Depression, Postpartum1
Insulin Resistance1
Mania1
Metabolic Syndrome1
Mood Disorders1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.